Most importantly, we demonstrate that monocytes from COVID-19 patients switch their phenotype and function from classical innate immune functions to a pro-thrombotic phenotype, with increased capacity to aggregate platelets.
Most importantly, we demonstrate that monocytes from COVID-19 patients switch their phenotype and function from classical innate immune functions to a pro-thrombotic phenotype, with increased capacity to aggregate platelets.